
    
      All eligible patients will receive Endostar in combination with Gemcitabine plus
      Platinum-based chemotherapy for 4 cycles (21 days for each cycle). Endostar treatment will
      continue after completion of chemotherapy cycles until disease progression. Efficacy will be
      evaluated every two cycles.
    
  